Clinical data as prognostic tools in the management of renal cell carcinoma (RCC)

被引：0
|
作者：
Yap, N. Y. [1 ]
Ng, K. L. [1 ,2 ]
Ong, T. A. [1 ,3 ]
Pailoor, J. [3 ,4 ]
Razack, A. H. A. [1 ,3 ]
Gobe, G. [2 ]
Morais, C. [2 ]
Rajandram, R. [1 ,2 ,3 ,5 ]
机构：
[1] Fac Med, Dept Surg, Kuala Lumpur, Malaysia
[2] Univ Queensland, Translat Res Inst, Ctr Kidney Dis Res, Sch Med, Brisbane, Qld, Australia
[3] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia
[4] Fac Med, Dept Pathol, Kuala Lumpur, Malaysia
[5] Univ Malaya, Canc Res Inst, Fac Med, Kuala Lumpur, Malaysia
来源：
BJU INTERNATIONAL | 2014年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
269
引用
收藏
页码：129 / 130
页数：2
相关论文
共 50 条
  • [31] Effectiveness of sequential treatment of advanced or metastatic renal cell carcinoma (MRCC). Outcome data from the clinical RCC Registry
    Goebell, P. J.
    Mueller, L.
    Lueck, A.
    Overkamp, F.
    Vogt, M.
    Marschner, N.
    ONKOLOGIE, 2013, 36 : 8 - +
  • [32] Quality-of-Life (QoL) data published by clinical trials supporting drug approvals for renal cell carcinoma (RCC)
    Seadon, R. E.
    Tapia, J. C.
    Matthews, D.
    Gavira-Diaz, J.
    Santoni, M.
    Young, M. N.
    Blondel, L.
    Flippot, R.
    Anguera, G.
    Frazer, R.
    Maroto Rey, J. P.
    ANNALS OF ONCOLOGY, 2024, 35 : S1192 - S1192
  • [33] Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC
    Turco, Fabio
    Tucci, Marcello
    Di Stefano, Rosario Francesco
    Samuelly, Alessandro
    Bungaro, Maristella
    Audisio, Marco
    Pisano, Chiara
    Di Maio, Massimo
    Scagliotti, Giorgio Vittorio
    Buttigliero, Consuelo
    ENDOCRINE-RELATED CANCER, 2021, 28 (07) : R207 - R216
  • [34] Renal cell carcinoma (RCC) following bariatric surgery
    Srikanth, MS
    Fox, SR
    Oh, KH
    Ward, K
    Sun, H
    Keskey, T
    Fox, KM
    Fox, ER
    OBESITY SURGERY, 2004, 14 (07) : 930 - 930
  • [35] Repurposing of ketorolac for the treatment of renal cell carcinoma (RCC)
    Ghosalkar, Jeevan Deepak
    Raut, Siddhika Rajiv
    Thekkumpurath, Mariamma Charles
    Malhotra, Geena
    Joshi, Kalpana Sanjay
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [36] Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC
    Waldert, Matthias
    Haitel, Andrea
    Marberger, Michael
    Katzenbeisser, Daniela
    Ozsoy, Mehmet
    Stadler, Elisabeth
    Remzi, Mesut
    BJU INTERNATIONAL, 2008, 102 (10) : 1381 - 1384
  • [37] ACCESSORY NIPPLES (AN) AND RENAL-CELL CARCINOMA (RCC)
    GOEDERT, JJ
    MCKEEN, EA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 465 - 465
  • [38] Renal Cell Carcinoma: Molecular and Genetic Markers as New Prognostic and Therapeutic Tools
    Filosa, Alessandra
    Fabiani, Andrea
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2008, 30 (06): : 341 - 343
  • [39] Clinical and prognostic features of chromophobe renal cell carcinoma.
    Morante, Zaida
    Gomez, Henry
    Pinto, Joseph A.
    Flores, Claudio J.
    Morante Deza, Carlos Manuel
    Cano, Luis
    Taxa, Luis
    Neciosup, Silvia P.
    Araujo, Jhajaira
    Mas, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Characterization of renal cell carcinoma (RCC) with VHL mutation
    Zhang, Y.
    Yang, T.
    Wang, W.
    Wang, H.
    Lou, F.
    Cao, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1320 - S1320
12345